share_log

RBC Capital Maintains Outperform on Mind Medicine, Raises Price Target to $22

Moomoo 24/7 ·  Mar 8 05:36

RBC Capital analyst Brian Abrahams maintains Mind Medicine (NASDAQ:MNMD) with a Outperform and raises the price target from $15 to $22.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment